Accenture
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Dose-finding Study in Platinum-Resistant Ovarian Cancer Recurrent Platinum-resistant Ovarian Cancer | Phase 1 / Phase 2 | 2012-11-01 |
| Completed | A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV) Postoperative Nausea and Vomiting | Phase 2 | 2012-02-01 |
| Completed | Single Dose Study of GSK1440115 in Patients With Asthma Asthma | Phase 1 | 2011-08-01 |
| Completed | Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV) Post-Operative Nausea and Vomiting (PONV) | Phase 1 | 2011-05-01 |
| Completed | Repeat Dose Safety Study for Compound to Treat Asthma Asthma | Phase 1 | 2010-09-01 |
| Completed | Repeat Dose Safety Study for Compound to Treat Hematologic Cancer Hematologic Malignancies | Phase 1 / Phase 2 | 2009-07-01 |